切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2017, Vol. 11 ›› Issue (02) : 102 -105. doi: 10.3877/cma.j.issn.1674-0807.2017.02.009

综述

植入式静脉输液港并发症及处理的研究进展
陈莉1, 罗凤1,(), 蔡明1   
  1. 1.400016 重庆医科大学附属第一医院内分泌乳腺外科
  • 收稿日期:2016-05-23 出版日期:2017-04-01
  • 通信作者: 罗凤
  • 基金资助:
    重庆市科学技术委员会资助项目(cstc2016shmszx130024)

Complications of implantable intravenous infusion port and management

Li Chen, Feng Luo(), Ming Cai   

  • Received:2016-05-23 Published:2017-04-01
  • Corresponding author: Feng Luo
引用本文:

陈莉, 罗凤, 蔡明. 植入式静脉输液港并发症及处理的研究进展[J/OL]. 中华乳腺病杂志(电子版), 2017, 11(02): 102-105.

Li Chen, Feng Luo, Ming Cai. Complications of implantable intravenous infusion port and management[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2017, 11(02): 102-105.

植入式静脉输液港留置时间长、并发症少、外形美观,近年来国内各大医院开始将其运用于临床,但目前国内医院对输液港相关并发症的预防和处理尚缺乏系统的相关知识,笔者对输液港植入时及临床使用中发生的主要并发症的原因、临床表现和处理措施进行综合分析,为医务工作者在临床上合理预防、及时发现及处理其相关并发症提供参考。

[1]
Fan L, Strasser-Weippl K, Li JJ,et al. Breast cancer in China[J].Lancet Oncol,2014,15(7):e279-289.
[2]
Piredda M,Biagioli V,Giannarelli D, et al. Improving cancer patients'knowledge about totally implantable access port: a randomized controlled trial[J].Support Care Cancer,2016,24(2):833-841.
[3]
An H, Ryu CG, Jung EJ,et al. Insertion of totally implantable central venous access devices by surgeons[J]. Ann Coloproctol,2015,31(2):63-67.
[4]
刘冰,尹杰.完全植入式静脉输液港手术方式及并发症研究进展[J/CD].中华临床医师杂志(电子版),2014,8(20):3704-3708.
[5]
孙玉巧,周涛,李云涛.完全植入式静脉输液港的临床应用[J]. 中华外科杂志,2014,52(8):608-611.
[6]
Akmangit I,Dede D,Daglioglu E,et al. A comparative study of lowprofile and regular type totally implantable venous access devices in patients with malignant tumors: retrospective analysis of 4501 implantations[J]. Int J Hematol Oncol,2014,24(2):97-105.
[7]
李剑,杜端明,邱水波,等. 不同路径植入输液港的临床应用研究[J].中国基层医药,2015,22(10):1520-1523.
[8]
Barbetakis N, Asteriou C, Kleontas A, et al. Totally implantable central venous access ports. analysis of 700 cases[J]. J Surg Oncol,2011,104(6):654-656.
[9]
周媛,周倩.肿瘤患者植入式静脉输液港并发症及其护理对策[J].江苏医药,2015,41(5):613-614.
[10]
Fankhauser GT,Fowl RJ,Stone WM,et al.Elimination of pneumothorax and hemothorax during placement of implantable venous access ports using ultrasound and fluoroscopiguidance[J]. Vascular,2013,21(6):345-348.
[11]
Elsharkawy H, Lewis BS, Steiger E, et al. Post placement positional atrial fibrillation and peripherally inserted central catheters [J].Minerva Anestesiol,2009,75(7-8):471-474.
[12]
刘艳萍,钱丰,谢潇,等.彩色多普勒超声实时引导经外周静脉穿刺植入中心静脉导管的实用价值[J].临床超声医学杂志,2012,14(3):195-197.
[13]
Lebeaux D, Fernández-Hidalgo N, Chauhan A,et al. Management of infections related to totally implantable venous-access ports: challenges and perspectives[J]. Lancet Infect Dis,2014,14,(2):146-159.
[14]
Wang TY, Lee KD, Chen PT,et al. Incidence and risk factors for central venous access port-related infection in Chinese cancer patients[J].J Formos Med Assoc,2015,114(11):1055-1060.
[15]
Wildgruber M,Lueg C,Borgmeyer S,et al.Polyurethane versus silicone catheters for central venous port devices implanted at the forearm[J].Eur J Cancer,2016,59:113-124.
[16]
Sievert DM, Ricks P, Edwards JR, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention,2009-2010[J]. Infect Control Hosp Epidemiol,2013,34(1):1-14.
[17]
Vidal M, Genillon JP,Forestier E,et al.Outcome of totally implantable venous-access port-related infections [J]. Med Mal Infect, 2016,46(1):32-38.
[18]
Bustos C, Aguinaga A, Carmona-Torre F, et al. Long-term catheterization: current approaches in the diagnosis and treatment of port-related infections [J]. Infect Drug Resist,2014,7:25-35.
[19]
Silva TN, Mendes ML, Abrão JM, et al. Successful prevention of tunneled central catheter infection by antibiotic lock therapy using cefazolin and gentamicin[J]. Int Urol Nephrol,2013,45(5):1405-1413.
[20]
Wildgruber M,Borgmeyer S, Haller B,et al. Short-term and long-term outcome of radiological-guided insertion of central venous access port devices implanted at the forearm:a retrospective monocenter analysis in 1704 patients[J].Eur Radiol,2015,25(3):606-616.
[21]
Boddi M, Villa G, Chiostri M,et al. Incidence of ultrasound-detected asymptomatic long-term central vein catheter-related thrombosis and fibrin sheath in cancer patients[J]. Eur J Haematol, 2015,95(5):472-479.
[22]
Ma LI, Liu Y, Wang J,et al. Totally implantable venous access port systems and associated complications: a single-institution retrospective analysis of 2996 breast cancer patients[J]. Mol Clin Oncol,2016,4(3):456-460.
[23]
李小庭,刘丁,王亚彬,等.早期应用尿激酶预防及治疗长期透析导管纤维蛋白鞘[J].南方医科大学学报,2014,34(11):1668-1671.
[24]
Almasi-Sperling V, Hieber S, Lermann J,et al. Femoral placement of totally implantable venous access ports in patients with bilateral breast cancer[J].Geburtshilfe Frauenheilkd,2016,76(1):53-58.
[25]
Fischer L, Knebel P, Schröder S,et al. Reasons for explantation of totally implantable access ports: a multivariate analysis of 385 consecutive patients[J]. Ann Surg Oncol,2008,15(4):1124-1129.
[26]
Goltz JP,Schmid JS,Ritter CO,et al. Identification of risk factors for catheter-related thrombosis in patients with totally implantable venous access ports in the forearm[J]. J Vasc Access,2012,13(1):79-85.
[27]
Goltz JP, Scholl A, Ritter CO, et al. Peripherally placed totally implantable venous-access port systems of the forearm: clinical experience in 763 consecutive patients [J]. Cardiovasc Intervent Radiol,2010,33(6):1159-1167.
[28]
Gonda SJ, Li R. Principles of subcutaneous port placement[J]. Tech Vasc Interv Radiol,2011,14(4):198-203.
[29]
Chang YF, Lo AC, Tsai CH, et al. Higher complication risk of totally implantable venous access port systems in patients with advanced cancer— a single institution retrospective analysis[J]. Palliat Med,2013,27(2):185-191.
[30]
徐波,耿翠芝.肿瘤治疗血管通道安全指南[M].北京:中国协和医科大学出版社,2015:143.
[31]
Cho JB,Park IY,Sung KY,et al. Pinch-off syndrome[J].J Korean Surg Soc,2013,85(3):139-144.
[32]
Viviani E, Giribono AM, Ferrara D, et al.Chest pain due to pinch-off syndrome: radiological findings and endovascular rescue[J].Clin Ter,2016,167(1):13-15.
[33]
Le A, Patel S. Extravasation of noncytotoxic drugs: a review of the literature[J]. Ann Pharmacother,2014,48(7):870-886.
[34]
Ben Kridis W, Sahnoun M, Maraoui H,et al. Fracture at catheter of totally implantable venous access port with migration into the right pulmonary artery: a serious complication[J].Acta Clin Belg,2016,13:1-4.
[35]
胡飞翔,蔡明,淳林,等. 输液港在乳腺癌患者化疗中的临床应用[J/CD].中华乳腺病杂志(电子版),2014,8(1):59-61.
[36]
Rouzrokh M, Shamsian BS, KhaleghNejad Tabari A, et al. Totally implantable subpectoral vs. subcutaneous port systems in children with malignant diseases[J]. Arch Iran Med,2009,12(4):389-394.
[37]
Xiao SP, Xiong B, Chu J,et al.Fracture and migration of implantable venous access port catheters: cause analysis and management of 4 cases[J]. J Huazhong Univ Sci Technolog,2015,35(5):763-765.
[38]
Cai Y, Li Y, Deng Y, et al.Upper arm vein versus subclavian vein for totally implantable venous access ports for patients with gastrointestinal malignancy: a retrospective comparison of complications[J]. Zhonghua Wei Chang Wai Ke Za Zhi,2015,18(10):1002-1005.蔡永华,黎燕红,叶俊文,等.上臂静脉与锁骨下静脉入路输液港应用于胃肠肿瘤化疗的并发症比较[J]. 中华胃肠外科杂志,2015,18(10):1002-1005.
[39]
Mori Y, Nagayama S, Kawamura J,et al. A retrospective analysis on the utility and complications of upper arm ports in 433 cases at a single institute[J].Int J Clin Oncol,2016,21(3):474-482.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[3] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[4] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[5] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[6] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[7] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[8] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[9] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[10] 康婵娟, 张海涛, 翟静洁. 胰管支架置入术治疗急性胆源性胰腺炎的效果及对患者肝功能、炎症因子水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 667-670.
[11] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[12] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[13] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[14] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[15] 杭轶, 杨小勇, 李文美, 薛磊. 可控性低中心静脉压技术在肝切除术中应用的最适中心静脉压[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 813-817.
阅读次数
全文


摘要